Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ Dynamics
线粒体-SR 束缚:其在心脏生物能学和 Ca2 动力学中的作用
基本信息
- 批准号:8657284
- 负责人:
- 金额:$ 46.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-12 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdrenergic AgentsAgingAreaBiochemicalBiochemistryBioenergeticsCalciumCalcium ionCardiacCardiac MyocytesCessation of lifeColorComplementCouplingDataDiabetes MellitusDiseaseElectric StimulationElectron TransportElectronsElementsEndoplasmic ReticulumExposure toFailureFractionationFrequenciesGenerationsGeneticHeartHeart DiseasesHeart MitochondriaHeart failureHomeostasisImageImaging TechniquesInjuryInner mitochondrial membraneKnock-outLeadLeftLifeLightMediatingMetabolic DiseasesMitochondriaMolecularMusMuscle CellsMyocardial IschemiaMyocardiumNADPNeurodegenerative DisordersOrganellesOuter Mitochondrial MembraneOxidative StressPhysiologic pulsePhysiologicalPredispositionProcessProductionProtein FamilyProteinsRattusReactive Oxygen SpeciesRegulationReperfusion InjuryResearchResolutionRoleSarcoplasmic ReticulumSecureSourceStressStructureTestingTherapeuticTimeTranslatingVariantVentricularWorkadrenergicclinical phenotypeclinically relevantdensitygenetic manipulationheart cellhuman diseaseinterdisciplinary approachmitochondrial dysfunctionmitochondrial permeability transition poreoverexpressionpublic health relevancesudden cardiac deathtooluptake
项目摘要
DESCRIPTION (provided by applicant): In cardiac muscle, uptake of Ca2+ by mitochondria during the excitation-contraction (EC) coupling is important for synchronizing ATP production with the needs of contraction (excitation-bioenergetics (EB) coupling). However, an integrative mechanism to describe the EB coupling is missing mainly due to the lack of information about the molecular identities of several key proteins involved in this process. Recent ground-breaking studies have shown that mitofusin 2 (Mfn2) is responsible for tethering endoplasmic reticulum to mitochondria. Moreover, several components of the mitochondrial Ca2+ uniporter (mtCU) including its pore unit (MCU) have been uncovered. These progresses open up a new opportunity for applying molecular tools to elucidate the mechanisms of mitochondria-sarcoplasmic reticulum (MITO-SR) tethering in controlling bioenergetics and Ca2+ dynamics. Our labs were the first to show a privileged transport of Ca2+ from SR to mitochondria in cardiomyocytes due to their juxtaposition, secured by tethering with Mfn2 family proteins. Dr. Sheu has a long standing expertise in using genetic and physiological tools to study in and ex vivo the cardiac mitochondrial Ca2+ and reactive oxygen species (ROS) regulation and Dr. Csordas has a strong track record in using biochemical and imaging techniques to investigate MITO-SR tethering and local Ca2+ crosstalk. Together, we will combine these interdisciplinary approaches to test the hypothesis that MITO-SR tethering via Mfn2 family proteins creates a micro-domain of high Ca2+ between these two organelles during EC coupling. Moreover, mtCUs are clustered in the region of inner mitochondrial membrane (IMM) that is in proximity with SR. Losses of this juxtaposition decrease EB coupling efficiency that leads to energy deficiency and oxidative stress and subsequent heart failure (HF). Three specific aims are: 1) to identify the tethering components that bridge MITO-SR associations. Hypothesis: Mfn2, possibly a truncated form, aligns SR with mitochondrial contact points. 2) To determine the distribution of mtCU in the IMM. Hypothesis: mtCU is preferentially localized in the areas where mitochondria and SR are in contact. 3) To elucidate the mechanisms by which the disrupted MITO-SR association leads to HF. Hypothesis: The loss of MITO-SR association leads to the inefficiency of EB coupling, as a result, electron transport chain activities and matrix NADPH levels decrease, which cause ROS to increase. The increase in ROS together with the decrease in ATP enhances the susceptibility of mitochondrial permeability transition pore for opening, especially under the energy-demanding stresses, which leads to cardiac injury and failure. The destruction of mitochondrial Ca2+ homeostasis is a key element for leading to mitochondrial dysfunction-associated clinical phenotypes including heart diseases (e.g. HF), neurodegenerative diseases, metabolic diseases (diabetes), and aging. Because MITO-SR juxtaposition is a critical factor in controlling mitochondrial Ca2+ dynamics, it is of scientific importance and clinical relevance that the present proposal will bring forth the molecular mechanism underlying the cardiac MITO-SR tethering and translate this unique structure to the physiological regulation of mitochondrial Ca2+ influx in bioenergetics and to the pathological implication of energy deficiency and oxidative stress in HF.
描述(由申请人提供):在心肌中,兴奋-收缩(EC)偶联期间线粒体对Ca 2+的摄取对于使ATP产生与收缩需求同步(兴奋-生物能量学(EB)偶联)非常重要。然而,一个综合的机制来描述EB耦合是缺失的,主要是由于缺乏信息的分子身份的几个关键蛋白质参与这一过程。最近的突破性研究表明,线粒体融合蛋白2(Mfn 2)负责将内质网拴系到线粒体。此外,线粒体Ca ~(2+)单向转运体(mtCU)包括其孔单元(MCU)的几种组分已被发现。这些进展开辟了一个新的机会,应用分子工具来阐明的机制,线粒体-肌浆网(MITO-SR)的束缚在控制生物能量学和钙动力学。我们的实验室是第一个显示Ca 2+从SR到心肌细胞线粒体的特权转运的实验室,这是由于它们的并置,通过与Mfn 2家族蛋白的束缚来保证。Sheu博士在使用遗传和生理工具研究体内和体外心脏线粒体Ca 2+和活性氧(ROS)调节方面具有长期的专业知识,Csordas博士在使用生物化学和成像技术研究MITO-SR束缚和局部Ca 2+串扰方面具有良好的记录。总之,我们将联合收割机这些跨学科的方法来测试的假设,通过Mfn 2家族蛋白质的MITO-SR拴在EC耦合过程中创建一个高钙离子微域之间的这两个细胞器。此外,mtCU聚集在与SR接近的线粒体内膜(IMM)区域。这种并置的损失降低EB偶联效率,导致能量缺乏和氧化应激以及随后的心力衰竭(HF)。三个具体目标是:1)识别桥接MITO-SR关联的系留组件。假设:Mfn 2,可能是一种截短的形式,将SR与线粒体接触点对齐。2)确定mtCU在IMM中的分布。假设:线粒体CU优先定位于线粒体和SR接触的区域。3)阐明线粒体-SR结合破坏导致心力衰竭的机制。假设:MITO-SR结合的丧失导致EB偶联的无效性,其结果是电子传递链活性和基质NADPH水平降低,这导致ROS增加。ROS的增加和ATP的减少增加了线粒体通透性转换孔开放的敏感性,特别是在能量需求应激下,导致心肌损伤和衰竭。线粒体Ca 2+稳态的破坏是导致线粒体功能障碍相关临床表型的关键因素,所述临床表型包括心脏病(例如HF)、神经退行性疾病、代谢疾病(糖尿病)和衰老。由于MITO-SR并置是控制线粒体Ca 2+动力学的关键因素,因此本提案将提出心脏MITO-SR束缚的分子机制,并将这种独特的结构转化为生物能量学中线粒体Ca 2+内流的生理调节以及HF中能量缺乏和氧化应激的病理意义,这具有科学重要性和临床意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GYORGY CSORDAS其他文献
GYORGY CSORDAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GYORGY CSORDAS', 18)}}的其他基金
ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease
钙信号传导、能量代谢和肝脏疾病中的内质网线粒体通讯
- 批准号:
10785141 - 财政年份:2021
- 资助金额:
$ 46.13万 - 项目类别:
ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease
钙信号传导、能量代谢和肝脏疾病中的内质网线粒体通讯
- 批准号:
10631482 - 财政年份:2021
- 资助金额:
$ 46.13万 - 项目类别:
ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease
钙信号传导、能量代谢和肝脏疾病中的内质网线粒体通讯
- 批准号:
10555276 - 财政年份:2021
- 资助金额:
$ 46.13万 - 项目类别:
ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease
钙信号传导、能量代谢和肝脏疾病中的内质网线粒体通讯
- 批准号:
10211656 - 财政年份:2021
- 资助金额:
$ 46.13万 - 项目类别:
ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease
钙信号传导、能量代谢和肝脏疾病中的内质网线粒体通讯
- 批准号:
10378151 - 财政年份:2021
- 资助金额:
$ 46.13万 - 项目类别:
Structural-functional zoning of the mitochondrion in cardiac Ca2+, ROS, and energetics regulation
线粒体在心脏 Ca2 、ROS 和能量调节中的结构功能分区
- 批准号:
9762152 - 财政年份:2018
- 资助金额:
$ 46.13万 - 项目类别:
Structural-functional zoning of the mitochondrion in cardiac Ca2+, ROS, and energetics regulation
线粒体在心脏 Ca2 、ROS 和能量调节中的结构功能分区
- 批准号:
9913581 - 财政年份:2018
- 资助金额:
$ 46.13万 - 项目类别:
Study of the mitochondrial-cellular response to environmental stress by flourescence imaging
通过荧光成像研究线粒体细胞对环境应激的反应
- 批准号:
9513726 - 财政年份:2017
- 资助金额:
$ 46.13万 - 项目类别:
Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ Dynamics
线粒体-SR 束缚:其在心脏生物能学和 Ca2 动力学中的作用
- 批准号:
10534750 - 财政年份:2014
- 资助金额:
$ 46.13万 - 项目类别:
Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ Dynamics
线粒体-SR 束缚:其在心脏生物能学和 Ca2 动力学中的作用
- 批准号:
8803808 - 财政年份:2014
- 资助金额:
$ 46.13万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 46.13万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 46.13万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 46.13万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 46.13万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 46.13万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 46.13万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 46.13万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 46.13万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 46.13万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 46.13万 - 项目类别: